Podcast

Pharmacy Focus Episode 25: The Multiple Myeloma Dispensing Project

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.


In this week's episode, we will be discussing the Association of Community Cancer Center’s Multiple Myeloma Dispensing Project with Kirollos Hanna, oncology pharmacy manager at M Health Fairview. If you would like to nominate a pharmacist or pharmacy staff member as a Pharmacy Hero, email AAntrim@pharmacytimes.com!

Related Videos
The EMPOWER-Lung 1 Trial: Five-Year Outcomes of Cemiplimab Monotherapy in Advanced NSCLC
Patient receiving cancer care from provider -- Image credit: Rido | stock.adobe.com
Patient taking prescription medicine -- Image credit: Rawpixel.com | stock.adobe.com
Related Content
3d rendered illustration of bowel cancer 3D illustration - Image credit: appledesign | stock.adobe.com
October 9th 2024

Study Finds High Dose Vitamin D3 Does Not Benefit Survival for Metastatic Colorectal Cancer

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Image Credit: © Impress Designers - stock.adobe.com
October 7th 2024

Treosulfan Improves Survival and Lowers Mortality Prior to Allo-HSCT in Patients With Myelofibrosis

Alexandra Gerlach, Associate Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

Microscopic view of high grade follicular lymphoma with marginal zone differentiation
October 4th 2024

Acalabrutinib-Rituximab Combination Effective in Relapsed/Refractory, Treatment-Naive Follicular Lymphoma

Luke Halpern, Assistant Editor
FDA Approval Seal -- Image credit: B-design | stock.adobe.com
October 4th 2024

FDA Approves Nivolumab for the Treatment of Adult Patients With Resectable NSCLC

Gillian McGovern, Assistant Editor